Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study
William E. Moody, Boyang Liu, Hani Mahmoud‐Elsayed, Jonathan Senior, Sasha Lalla, Ayisha Mehtab Khan‐Kheil, Stewart Brown, Abdullah Saif, Alastair J. Moss, William Bradlow, Jeffrey Khoo, Mubarak Ahamed, Christopher McAloon, Sandeep S Hothi, Richard P. Steeds
Abstract
Abnormalities in cardiac structure and function are common in patients hospitalized with severe COVID-19 pneumonia who have evidence of myocardial injury based on elevated high-sensitivity cardiac troponin (HScTn).1 Studies performing transthoracic echocardiography (TTE) in an acute setting have consistently demonstrated a high prevalence of right ventricular (RV) dilation and dysfunction, a finding that is associated with early mortality independent of standard clinical and biomarker risk stratification.